Probiotics  	Probiotics  	 NNP	B-NP
and  	and  	 CC	O
Helicobacter  	Helicobacter  	 NNP	B-NP
pylori  	pylori  	 JJ	I-NP
infection  	infection  	 NN	I-NP
in  	in  	 IN	O
children  	children  	 NNS	O
Approximately  	Approximately  	 RB	O
50  	50  	 CD	O
percent  	percent  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
world  	world  	 NN	O
population  	population  	 NN	O
is  	is  	 VBZ	O
infected  	infected  	 VBN	O
with  	with  	 IN	O
Helicobacter  	Helicobacter  	 NNP	B-NP
pylori  	pylori  	 NNS	I-NP
( 	( 	 -LRB-	O
H.  	H.  	 NNP	O
pylori 	pylori 	 CD	B-NP
) 	) 	 -RRB-	O
,  	,  	 ,	O
with  	with  	 IN	O
the  	the  	 DT	O
highest  	highest  	 JJS	O
prevalence  	prevalence  	 JJ	B-NP
rates  	rates  	 NNS	I-NP
in  	in  	 IN	O
developing  	developing  	 VBG	O
countries 	countries 	 NNS	O
.  	.  	 .	O
The  	The  	 DT	O
current  	current  	 JJ	O
guidelines  	guidelines  	 NNS	O
suggest  	suggest  	 VBP	O
the  	the  	 DT	O
use  	use  	 NN	O
of  	of  	 IN	O
triple  	triple  	 JJ	O
therapy  	therapy  	 NN	O
as  	as  	 IN	O
first  	first  	 JJ	O
choice  	choice  	 NN	B-NP
treatment  	treatment  	 NN	I-NP
of  	of  	 IN	I-NP
Helicobacter  	Helicobacter  	 NNP	I-NP
pylori  	pylori  	 JJ	I-NP
infection 	infection 	 NN	I-NP
,  	,  	 ,	O
although  	although  	 IN	O
the  	the  	 DT	O
eradication  	eradication  	 JJ	B-NP
failure  	failure  	 NN	I-NP
rate  	rate  	 NN	I-NP
is  	is  	 VBZ	O
more  	more  	 JJR	O
than  	than  	 IN	O
30  	30  	 CD	O
percent 	percent 	 NN	O
.  	.  	 .	O
Current  	Current  	 JJ	B-NP
interest  	interest  	 NN	I-NP
in  	in  	 IN	O
probiotics  	probiotics  	 NN	B-NP
as  	as  	 IN	O
therapeutic  	therapeutic  	 JJ	B-NP
agents  	agents  	 NNS	I-NP
against  	against  	 IN	O
Helicobacter  	Helicobacter  	 NNP	B-NP
pylori  	pylori  	 NN	I-NP
is  	is  	 VBZ	O
stimulated  	stimulated  	 VBN	O
by  	by  	 IN	O
the  	the  	 DT	O
increasing  	increasing  	 JJ	O
resistance  	resistance  	 NN	O
of  	of  	 IN	O
pathogenic  	pathogenic  	 JJ	B-NP
bacteria  	bacteria  	 NNS	I-NP
to  	to  	 TO	O
antibiotics 	antibiotics 	 VB	O
,  	,  	 ,	O
thus  	thus  	 RB	O
the  	the  	 DT	O
interest  	interest  	 NN	O
for  	for  	 IN	O
alternative  	alternative  	 JJ	O
therapies  	therapies  	 NN	O
is  	is  	 VBZ	O
a  	a  	 DT	O
real  	real  	 JJ	O
actual  	actual  	 JJ	O
topic 	topic 	 NN	O
.  	.  	 .	O
Available  	Available  	 JJ	O
data  	data  	 NNS	O
in  	in  	 IN	O
children  	children  	 NNS	O
indicate  	indicate  	 VBP	O
that  	that  	 IN	O
probiotics  	probiotics  	 NNS	B-NP
seem  	seem  	 VBP	O
to  	to  	 TO	O
be  	be  	 VB	O
efficacious  	efficacious  	 VBN	O
for  	for  	 IN	O
the  	the  	 DT	O
prevention  	prevention  	 NN	O
of  	of  	 IN	O
antibiotic  	antibiotic  	 NN	O
associated  	associated  	 VBN	B-NP
side-effects 	side-effects 	 JJ	I-NP
,  	,  	 ,	O
and  	and  	 CC	O
might  	might  	 MD	O
be  	be  	 VB	O
of  	of  	 IN	O
help  	help  	 NN	O
for  	for  	 IN	O
the  	the  	 DT	O
prevention  	prevention  	 NN	O
of  	of  	 IN	O
Helicobacter  	Helicobacter  	 NNP	B-NP
pylori  	pylori  	 NN	I-NP
complications  	complications  	 NNS	I-NP
by  	by  	 IN	O
decreasing  	decreasing  	 FW	B-NP
Helicobacter  	Helicobacter  	 FW	I-NP
pylori  	pylori  	 FW	I-NP
density  	density  	 FW	I-NP
and  	and  	 CC	O
gastritis 	gastritis 	 NN	O
,  	,  	 ,	O
and  	and  	 CC	O
for  	for  	 IN	O
the  	the  	 DT	O
prevention  	prevention  	 NN	O
of  	of  	 IN	O
Helicobacter  	Helicobacter  	 NNP	B-NP
pylori  	pylori  	 NN	I-NP
colonization  	colonization  	 NNS	I-NP
or  	or  	 CC	O
re-infection  	re-infection  	 JJ	B-NP
by  	by  	 IN	O
inhibiting  	inhibiting  	 JJ	O
adhesion  	adhesion  	 NN	B-NP
to  	to  	 TO	O
gastric  	gastric  	 VB	B-NP
epithelial  	epithelial  	 JJ	I-NP
cells 	cells 	 NNS	I-NP
.  	.  	 .	O
There  	There  	 EX	O
is  	is  	 VBZ	O
no  	no  	 DT	O
clear  	clear  	 JJ	O
evidence  	evidence  	 NN	O
that  	that  	 IN	O
probiotics  	probiotics  	 NNS	B-NP
may  	may  	 MD	O
increase  	increase  	 VB	O
the  	the  	 DT	O
Helicobacter  	Helicobacter  	 NNP	B-NP
pylori  	pylori  	 VBD	O
eradication  	eradication  	 JJ	B-NP
rate 	rate 	 NN	I-NP
.  	.  	 .	O
